The effects of timing of buffet-meal presentation on energy intake following a nutrient preload in humans: relationships with gastrointestinal functions.
- Conditions
- ObesityDiet and Nutrition - ObesityOral and Gastrointestinal - Normal oral and gastrointestinal development and function
- Registration Number
- ACTRN12610000568011
- Lead Sponsor
- Christine Feinle-Bisset
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 16
Non-obese with a Body Mass Index (BMI) of 19-25kg/m2) and obese with a BMI >30kg/m2 and waist circumference > 102cm for males and >97cm for females.
Female subjects will be included on the basis that they are using an appropriate contraceptive method (i.e. oral contraceptive pill, diaphragm, Depo-Provera hormonal contraceptive injection, intrauterine device (IUD), Norplant method).
Significant gastrointestinal symptoms, disease or surgery. Current use of prescribed or non-prescribed medications (including vitamins and herbal supplements) which may affect energy metabolism, gastrointestinal (GI) function, body weight or appetite (e.g. domperidone and cisapride, anticholinergic drugs (e.g. atropine), metclopramide, erythromycin, hyoscine, orlistat, green tea extracts, Astragalus, St John's Wort etc). Significant illness as assessed by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method